Biotech

All Articles

OS Treatments refiles $6M IPO to fund HER2 drug, preclinical ADCs

.Operating system Therapies will certainly note on the NYSE American inventory substitution today vi...

ALX's fizzling CD47 action cost sends out sell spiraling down

.ALX Oncology's period 2 stomach cancer cells action price has diminished. After observing its CD47 ...

Ionis axes eye illness from intendeds of Roche-partnered prospect after data dissatisfy

.Yet Another of Ionis Pharmaceuticals' key midphase readouts has disappointed requirements, motivati...

Biogen's CEO mentioned no high-risk handle 2023. He prepares to be vibrant

.While Biogen's pharma peers are looking for late-stage possessions along with little danger, CEO Ch...

Instil refills pipe in $2B biobucks cope with ImmunOnco

.Instil Biography has been a biotech seeking a pipeline after it junked its own lead properties over...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually handed back rights to an early Alzheimer's condition course to Denali Therapies...

Takeda faucets brand-new head people oncology service-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings and retir...

Vertex, beaten by AATD again, drops 2 properties on dispose of pile

.Tip's attempt to treat an uncommon genetic disease has actually reached another trouble. The biotec...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of staff

.Vir Medical's second-quarter profits file had not been except huge headlines. The company invited a...

Galapagos stops CAR-T tissue treatment trial over Parkinsonism case

.Galapagos has actually paused enrollment in a trial of a BCMA-directed CAR-T cell therapy, pumping ...